Ketoprofen pharmacokinetics, efficacy, and tolerability in pediatric patients.
The NSAID ketoprofen is used widely in the management of inflammatory and musculoskeletal conditions, pain, and fever in children and adults. Pharmacokinetic studies show that drug exposure after a single intravenous dose is similar in children and adults (after dose normalization), and thus similar mg/kg bodyweight dosing may be used in children and adults. Ketoprofen crosses the blood-brain barrier and therefore has the potential to cause central analgesic effects. Ketoprofen has been investigated in children for the treatment of pain and fever, peri- and postoperative pain, and inflammatory pain conditions. The results of four clinical trials in febrile conditions with the oral syrup formulation indicate that ketoprofen is as effective as acetaminophen (paracetamol) and ibuprofen, allowing children to rapidly return to daily activities with improvements in sleep quality and appetite. Studies of ketoprofen in the management of postoperative pain indicate that ketoprofen is a highly effective analgesic when administered perioperatively for a variety of surgical types, by a variety of routes, and whether given preoperatively or postoperatively. For adenoidectomy, intravenous ketoprofen provided superior postoperative analgesic efficacy compared with placebo. Analgesic efficacy was similar with intravenous, intramuscular, or rectal routes of administration, but oral administration just before surgery was inferior to intravenous administration in this setting. In patients undergoing a tonsillectomy, intravenous ketoprofen was superior to intravenous tramadol in terms of the need for postoperative rescue analgesia, but did not remove the need for rescue opioid therapy in these patients. Intravenous ketoprofen had superior postoperative analgesic efficacy to placebo when given as an adjuvant to epidural sufentanil analgesia after major surgery. Oral ketoprofen has shown efficacy in the treatment of juvenile rheumatoid arthritis. Ketoprofen is generally well tolerated in pediatric patients. Most of the adverse events reported are mild and transient, and are similar to those observed with other NSAIDs. Long-term tolerability has not yet been fully established in children, but data from three studies in >900 children indicate that oral ketoprofen is well tolerated when administered for up to 3 weeks after surgery. In conclusion, ketoprofen is effective and well tolerated in children for the control of post-surgical pain and for the control of pain and fever in inflammatory conditions.
Kokki
Hannu
H
Department of Anesthesiology and Intensive Care, Kuopio University Hospital, University of Eastern Finland, Kuopio, Finland. hannu.kokki@kuh.fi
D002648:Child; D005334:Fever / Q000188:drug therapy; D006801:Humans; D007249:Inflammation / Q000188:drug therapy; D007660:Ketoprofen / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000494:pharmacology / Q000627:therapeutic use*; D059035:Perioperative Period
D007660:Ketoprofen
Paediatr Anaesth. 2001 Jan;11(1):59-64
11123733
Acta Anaesthesiol Scand. 1999 Jan;43(1):13-8
9926181
Paediatr Anaesth. 2002 May;12(4):313-6
11982837
Paediatr Anaesth. 2006 May;16(5):548-53
16677265
J Rheumatol. 1982 Jan-Feb;9(1):144-8
7045361
Dev Pharmacol Ther. 1988;11(6):347-56
3229281
J Clin Pharmacol. 2000 Apr;40(4):354-9
10761162
Middle East J Anaesthesiol. 1999 Feb;15(1):31-8
10068969
Acta Anaesthesiol Scand. 2002 Feb;46(2):184-9
11942868
Pediatrics. 2001 Sep;108(3):793-7
11533354
J Bone Joint Surg Am. 2002 Oct;84(10):1763-8
12377905
Paediatr Anaesth. 2003 Sep;13(7):574-8
12950856
Paediatr Anaesth. 2002 Feb;12(2):162-7
11882229
Clin Pharmacol Ther. 1987 Aug;42(2):137-41
3608347
Br J Anaesth. 1997 Nov;79(5):606-8
9422899
Br J Anaesth. 1999 Jun;82(6):886-9
10562784
Eur J Clin Pharmacol. 1980 Nov;18(5):407-14
7439263
Eur J Anaesthesiol Suppl. 1995 May;10:8-13
7641652
Clin Pharmacokinet. 2003;42(4):373-9
12648027
J Neurosurg Spine. 2007 Dec;7(6):631-6
18074688
Acta Anaesthesiol Scand. 1999 Aug;43(7):775-9
10456820
Clin Pharmacokinet. 1987 Mar;12(3):214-21
3581635
Arch Otolaryngol Head Neck Surg. 2002 Oct;128(10):1159-64
12365887
J Postgrad Med. 2003 Apr-Jun;49(2):123-6
12867686
Minerva Pediatr. 1995 May;47(5):199-205
7643821
Clin Drug Investig. 2010;30(4):251-8
20225908
Br J Anaesth. 2000 Dec;85(6):836-40
11732515
Eur J Clin Pharmacol. 1985;29(3):319-21
4076328
Clin Drug Investig. 2004;24(4):237-44
17516708
Int J Pediatr Otorhinolaryngol. 2002 Feb 1;62(2):143-50
11788147
Br J Anaesth. 1997 Jan;78(1):24-7
9059199
Paediatr Anaesth. 2000;10(5):531-5
11012958
J Bone Joint Surg Am. 2003 Apr;85(4):632-4
12672837
Scand J Rheumatol Suppl. 1976;1976(0):7-32
136040
Anesth Analg. 1999 Sep;89(3):652-8
10475299
Indian J Pediatr. 2009 Mar;76(3):287-91
19129989
N Engl J Med. 2002 Oct 3;347(14):1094-103
12362012
Br J Clin Pharmacol. 1995 Jul;40(1):73-5
8527271
Clin Pharmacokinet. 1990 Sep;19(3):197-217
2203580
Anesth Analg. 1970 Nov-Dec;49(6):924-34
5534693
Anesth Analg. 1997 Aug;85(2):400-5
9249121
Br J Anaesth. 2000 Aug;85(2):224-7
10992828
Yonsei Med J. 2005 Apr 30;46(2):245-51
15861498
Drugs. 2003;63(24):2709-23
14664651
Phys Ther. 2006 Mar;86(3):424-33
16506878
Paediatr Drugs. 2003;5(2):103-23
12529163
Clin Pharmacokinet. 2006;45(7):737-43
16802854
Br J Anaesth. 1998 Dec;81(6):870-4
10211011
Anesth Analg. 2006 May;102(5):1365-71
16632811
Anaesthesia. 1997 Jul;52(7):673-83
9244028
Acta Anaesthesiol Scand. 2002 Feb;46(2):194-8
11942870
Eur J Pain. 2007 Aug;11(6):694-9
17185016
Anesth Analg. 1999 May;88(5):1036-41
10320164
Clin Drug Investig. 2010;30(6):375-86
20380479
Paediatr Drugs. 2001;3(11):817-58
11735667
Eur J Clin Pharmacol. 2001 Nov;57(9):643-7
11791893